BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gingerich AD, Mousa JJ. Diverse Mechanisms of Protective Anti-Pneumococcal Antibodies. Front Cell Infect Microbiol 2022;12:824788. [DOI: 10.3389/fcimb.2022.824788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Banerjee K, Motley MP, Boniche-alfaro C, Bhattacharya S, Shah R, Ardizzone A, Fries BC, Larock CN. Patient-Derived Antibody Data Yields Development of Broadly Cross-Protective Monoclonal Antibody against ST258 Carbapenem-Resistant Klebsiella pneumoniae. Microbiol Spectr. [DOI: 10.1128/spectrum.01760-22] [Reference Citation Analysis]
2 Gingerich AD, Royer F, Mccormick AL, Scasny A, Vidal JE, Mousa JJ. Synergistic protection against secondary pneumococcal infection by human monoclonal antibodies targeting distinct epitopes.. [DOI: 10.1101/2022.04.20.488872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]